Skip to main content

Table 2 Follow-up pulmonary function tests

From: The unusual experience of managing a severe COVID-19 case at home: what can we do and where do we go?

Pulmonary Function Tests

Month

3rd Month

4th Month

6th Month

Parameter

Absolute Value

Predicted (%)

Absolute Value

Predicted (%)

Absolute Value

Predicted (%)

Spirometry

 FVC (L)

1.06

40%

1.31

49%

1.38

52%

 FEV1 (L)

0.92

44%

1.12

54%

1.13

54%

 FEV1/FVC (L)

0.87

111%

86.00

109%

81.70

104%

 FEF25–75% (L/s)

1.40

66%

1.71

80%

1.33

63%

DLCO

 DLCO

8.30

41%

12.10

60%

11.70

58%

 DLCO/VA (KCO)

4.52

85%

4.03

76%

4.32

82%

 TLC sb (L)

2.00

51%

3.15

80%

2.86

72%

6-MWT

 6-MWD (M)

264

55%

294

61%

359

75%

 Basal SpO2 (%)

93%

N/A

96%

N/A

97%

N/A

 Post-exercise SpO2 (%)

88%

N/A

91%

N/A

96%

N/A

  1. FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, FEF forced expiratory flow, DLCO diffusing capacity of carbon monoxide, VA alveolar ventilation, KCO carbon monoxide transfer coefficient, TLC total lung capacity, 6-MWT 6-m walk test, 6-MWD 6-m walk distance, SpO2 oxygen saturation
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us